Effect and mechanism of mylohyoid muscle magnetic stimulation and electrical stimulation on post-stroke dysphagia

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060557

Enrollment

Unknown

Registered

2022-06-04

Start date

2022-05-30

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

(Heathy subjects) Central magnetic stimulation:Magnetic stimulation of the cerebral cortex region of the mylohyoid muscle

(Heathy subjects) Peripheral magnetic stimulation:Peripheral magnetic stimulation of mylohyoid muscle

(Heathy subjects) Electrical stimulation:Electrical stimulation of mylohyoid muscle

(Stroke patients) Central magnetic stimulation:Magnetic stimulation of the cerebral cortex region of the mylohyoid muscle+Routine swallowing training

(Stroke patients)Peripheral magnetic stimulation:Peripheral magnetic stimulation of mylohyoid muscle+Routine swallowing training

(Stroke patients) Electrical stimulation :Electrical stimulation of mylohyoid muscle+Routine swallowing training

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Healthy subjects: (1) Aged 20-50 years; (2) Clear-headed, stable vital signs; (3) Able to understand and execute physician instructions; (4) With their consent to the study, sign an informed consent form before the study. 2. Stroke patients: (1) Age 40-80 years; (2) Clear mind, stable vital signs; (3) Able to understand and perform physician instructions; (4) With the consent of the patient or family to undergo this research and swallowing contrast examination, sign informed consent before the study.

Exclusion criteria

Exclusion criteria: 1. Cardiopulmonary and kidney or other important organ dysfunction; 2. Epilepsy history; 3. Previous nasopharyngeal cancer radiotherapy, head, neck or oral cancer after surgery or other structural head and neck lesions; 4. Intracranial metal devices; 5. Impaired consciousness or severe cognitive impairment; 6. Inability to cooperate with the examination; 7. Previous history of cerebral hemorrhage, subarachnoid hemorrhage, brain tumors, brain trauma or other neuropsychiatric system diseases; 8. Previous history of dysphagia.

Design outcomes

Primary

Measure	Time frame
Surface electromyography;Functional near-infrared spectroscopy;	—

Countries

China

Contacts

Public ContactJun Ni

The First Affiliated Hospital of Fujian Medical University

nijun1000@126.com+86 19890572216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026